Anti breast cancer drug. 2x Survival Rate – Fresh


Breast cancer is the most common type of cancer among Thai women and women worldwide. At present, the number of people with this disease is increasing every year. The initial stage of breast cancer often shows no signs or symptoms. The patient is aware that the cancer spreads to one third to four. Treatment for Breast Cancer Previous surgery, chemotherapy, anti-hormonal treatment, but in the last 1 year there have been other alternative treatments. After the United States Pfizer. Innovative drugs for breast cancer are spread and spread. In Thailand, this drug has been approved by medicine. Last year, Pfizer Thailand donated this drug to the Thai Oncology Association last year. For the treatment of 50 patients with metastatic breast cancer, Assoc, Prof. Dr. Viroj Sriroonpong, Head of Cancer Medical Excellence Center Completed King Chulalongkorn Memorial Hospital The President of the Thai Oncology Association said that the drug was an anticancer drug that inhibited the 4/6 CDK action, approved by Food and Drug Administration as the first drug. The first line is in patients with advanced stage breast cancer or metastatic ER + / HER 2-menopause. Viroj said that the drug had two formulas that would be used differently. The first formulation was used by patients who had never received hormonal treatment. […]

Post anti breast cancer drugs. Increase survival rates 2 times appear first in countries.


Source link